| UniProt ID | NHRF2_HUMAN | |
|---|---|---|
| UniProt AC | Q15599 | |
| Protein Name | Na(+)/H(+) exchange regulatory cofactor NHE-RF2 | |
| Gene Name | SLC9A3R2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 337 | |
| Subcellular Localization |
Endomembrane system Peripheral membrane protein . Nucleus . Apical cell membrane. Localizes with EZR and PODXL at the apical cell membrane of glomerular epithelium cells and the sides of the food processes (By similarity). Nuclear, in a punctate pa |
|
| Protein Description | Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. [PubMed: 18829453 May also act as scaffold protein in the nucleus.] | |
| Protein Sequence | MAAPEPLRPRLCRLVRGEQGYGFHLHGEKGRRGQFIRRVEPGSPAEAAALRAGDRLVEVNGVNVEGETHHQVVQRIKAVEGQTRLLVVDQETDEELRRRQLTCTEEMAQRGLPPAHDPWEPKPDWAHTGSHSSEAGKKDVSGPLRELRPRLCHLRKGPQGYGFNLHSDKSRPGQYIRSVDPGSPAARSGLRAQDRLIEVNGQNVEGLRHAEVVASIKAREDEARLLVVDPETDEHFKRLRVTPTEEHVEGPLPSPVTNGTSPAQLNGGSACSSRSDLPGSDKDTEDGSAWKQDPFQESGLHLSPTAAEAKEKARAMRVNKRAPQMDWNRKREIFSNF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 (in isoform 3) | Phosphorylation | - | 33.91 | 22199227 | |
| 6 (in isoform 3) | Phosphorylation | - | 32.39 | 22199227 | |
| 8 (in isoform 3) | Phosphorylation | - | 25.63 | 22199227 | |
| 20 (in isoform 3) | Phosphorylation | - | 21.89 | 22199227 | |
| 30 (in isoform 3) | Phosphorylation | - | 21.88 | 27251275 | |
| 43 (in isoform 2) | Phosphorylation | - | 31.49 | 24719451 | |
| 43 | Phosphorylation | IRRVEPGSPAEAAAL EEECCCCCHHHHHHH | 31.49 | 21712546 | |
| 56 | Ubiquitination | ALRAGDRLVEVNGVN HHHCCCEEEEECCEE | 4.60 | 29967540 | |
| 58 | Ubiquitination | RAGDRLVEVNGVNVE HCCCEEEEECCEECC | 34.55 | 29967540 | |
| 92 | Phosphorylation | LLVVDQETDEELRRR EEEEECCCHHHHHHH | 42.98 | - | |
| 102 | Phosphorylation | ELRRRQLTCTEEMAQ HHHHHHHHCHHHHHH | 14.72 | - | |
| 122 | Ubiquitination | AHDPWEPKPDWAHTG CCCCCCCCCCCCCCC | 44.06 | 29967540 | |
| 124 | Ubiquitination | DPWEPKPDWAHTGSH CCCCCCCCCCCCCCC | 62.41 | 29967540 | |
| 126 | Ubiquitination | WEPKPDWAHTGSHSS CCCCCCCCCCCCCCC | 9.57 | 29967540 | |
| 128 | Phosphorylation | PKPDWAHTGSHSSEA CCCCCCCCCCCCCHH | 32.41 | 27251275 | |
| 130 | Phosphorylation | PDWAHTGSHSSEAGK CCCCCCCCCCCHHCC | 22.73 | 25159151 | |
| 132 | Phosphorylation | WAHTGSHSSEAGKKD CCCCCCCCCHHCCCC | 31.41 | 27251275 | |
| 132 (in isoform 2) | Phosphorylation | - | 31.41 | 24719451 | |
| 133 | Phosphorylation | AHTGSHSSEAGKKDV CCCCCCCCHHCCCCC | 26.49 | 27251275 | |
| 138 | Ubiquitination | HSSEAGKKDVSGPLR CCCHHCCCCCCCHHH | 63.55 | 29967540 | |
| 141 | Phosphorylation | EAGKKDVSGPLRELR HHCCCCCCCHHHHHH | 44.84 | 27251275 | |
| 167 | Phosphorylation | GYGFNLHSDKSRPGQ CCCCCCCCCCCCCCC | 50.31 | 25159151 | |
| 169 | Ubiquitination | GFNLHSDKSRPGQYI CCCCCCCCCCCCCEE | 51.91 | 29967540 | |
| 171 | Ubiquitination | NLHSDKSRPGQYIRS CCCCCCCCCCCEEEE | 45.14 | 29967540 | |
| 178 | Ubiquitination | RPGQYIRSVDPGSPA CCCCEEEECCCCCHH | 22.70 | 29967540 | |
| 178 | Phosphorylation | RPGQYIRSVDPGSPA CCCCEEEECCCCCHH | 22.70 | 23403867 | |
| 180 | Ubiquitination | GQYIRSVDPGSPAAR CCEEEECCCCCHHHH | 42.99 | 29967540 | |
| 183 (in isoform 2) | Phosphorylation | - | 19.43 | 24719451 | |
| 183 | Phosphorylation | IRSVDPGSPAARSGL EEECCCCCHHHHHHC | 19.43 | 25159151 | |
| 237 | Ubiquitination | PETDEHFKRLRVTPT CCCHHHHHHCCCCCC | 53.05 | 29967540 | |
| 242 | Phosphorylation | HFKRLRVTPTEEHVE HHHHCCCCCCHHCCC | 20.33 | 28450419 | |
| 244 | Phosphorylation | KRLRVTPTEEHVEGP HHCCCCCCHHCCCCC | 44.64 | 28450419 | |
| 254 (in isoform 2) | Phosphorylation | - | 39.42 | 24719451 | |
| 254 | Phosphorylation | HVEGPLPSPVTNGTS CCCCCCCCCCCCCCC | 39.42 | 25159151 | |
| 257 | Phosphorylation | GPLPSPVTNGTSPAQ CCCCCCCCCCCCHHH | 31.17 | 25159151 | |
| 257 (in isoform 2) | Phosphorylation | - | 31.17 | 24719451 | |
| 260 | Phosphorylation | PSPVTNGTSPAQLNG CCCCCCCCCHHHCCC | 33.34 | 25159151 | |
| 261 | Phosphorylation | SPVTNGTSPAQLNGG CCCCCCCCHHHCCCC | 21.45 | 25159151 | |
| 261 (in isoform 2) | Phosphorylation | - | 21.45 | 24719451 | |
| 269 | Phosphorylation | PAQLNGGSACSSRSD HHHCCCCCCCCCCCC | 27.74 | 26657352 | |
| 272 | Phosphorylation | LNGGSACSSRSDLPG CCCCCCCCCCCCCCC | 28.62 | 28450419 | |
| 273 | Phosphorylation | NGGSACSSRSDLPGS CCCCCCCCCCCCCCC | 35.37 | 28450419 | |
| 275 | Phosphorylation | GSACSSRSDLPGSDK CCCCCCCCCCCCCCC | 45.51 | 23927012 | |
| 280 (in isoform 2) | Phosphorylation | - | 39.28 | 24275569 | |
| 280 | Phosphorylation | SRSDLPGSDKDTEDG CCCCCCCCCCCCCCC | 39.28 | 23927012 | |
| 282 | Ubiquitination | SDLPGSDKDTEDGSA CCCCCCCCCCCCCCC | 69.14 | 29967540 | |
| 284 (in isoform 2) | Phosphorylation | - | 41.54 | 28348404 | |
| 284 | Phosphorylation | LPGSDKDTEDGSAWK CCCCCCCCCCCCCCC | 41.54 | 23663014 | |
| 287 (in isoform 2) | Phosphorylation | - | 17.03 | 27732954 | |
| 288 | Phosphorylation | DKDTEDGSAWKQDPF CCCCCCCCCCCCCCC | 43.19 | 23403867 | |
| 291 (in isoform 1) | Ubiquitination | - | 44.53 | 21906983 | |
| 291 | Ubiquitination | TEDGSAWKQDPFQES CCCCCCCCCCCCCCC | 44.53 | 2190698 | |
| 292 (in isoform 2) | Phosphorylation | - | 53.56 | 25849741 | |
| 294 (in isoform 2) | Phosphorylation | - | 30.26 | 27732954 | |
| 298 | Phosphorylation | KQDPFQESGLHLSPT CCCCCCCCCCCCCCC | 35.55 | 21712546 | |
| 303 | Phosphorylation | QESGLHLSPTAAEAK CCCCCCCCCCHHHHH | 14.95 | 22167270 | |
| 305 | Phosphorylation | SGLHLSPTAAEAKEK CCCCCCCCHHHHHHH | 34.81 | 22167270 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 303 | S | Phosphorylation | Kinase | ARAF | P10398 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NHRF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NHRF2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183 AND SER-254, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275, AND MASSSPECTROMETRY. | |